![David Moatazedi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Moatazedi
Algemeen Directeur bij EVOLUS, INC.
Vermogen: 7 M $ op 31-05-2024
Profiel
David Moatazedi is currently the President, Chief Executive Officer & Director at Evolus, Inc. He is also serving as an Independent Director at Biomerica, Inc. Previously, he worked as an Independent Director at Obalon Therapeutics, Inc. from 2017 to 2020.
Prior to that, he held the position of Senior Vice President at Allergan, Inc. from 2016 to 2018.
He also worked as a District Manager at Novartis Pharmaceuticals Corp.
from 2002 to 2005.
Mr. Moatazedi completed his undergraduate degree at The California State University and holds an MBA from Pepperdine University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
EVOLUS, INC.
0.85% | 06-06-2024 | 533 349 ( 0.85% ) | 7 M $ | 31-05-2024 |
Actieve functies van David Moatazedi
Bedrijven | Functie | Begin |
---|---|---|
EVOLUS, INC. | Algemeen Directeur | 06-05-2018 |
BIOMERICA, INC. | Directeur/Bestuurslid | 07-12-2022 |
Eerdere bekende functies van David Moatazedi
Bedrijven | Functie | Einde |
---|---|---|
RESHAPE LIFESCIENCES INC. | Directeur/Bestuurslid | 30-06-2020 |
ALLERGAN, INC. | Corporate Officer/Principal | 01-05-2018 |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-03-2005 |
Opleiding van David Moatazedi
Pepperdine University | Masters Business Admin |
The California State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
EVOLUS, INC. | Health Technology |
BIOMERICA, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Obalon Therapeutics, Inc.
![]() Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated. The company was founded on January 2, 2008 and is headquartered in Carlsbad, CA. | Health Technology |
Allergan, Inc.
![]() Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |